Feb 1 (Reuters) - MGC Pharmaceuticals Ltd MXC.AX :
* CURRENTLY WORKING THROUGH NOW FINAL STEPS FOR ADMISSION OF ITS SHARES TO STANDARD SEGMENT OF MAIN MARKET OF LONDON STOCK EXCHANGE
* DUAL LISTING ONTO LONDON STOCK EXCHANGE PROCESS HAS MATERIALLY PROGRESSED IN JANUARY, WHICH IS NOW EXPECTED TO BE COMPLETED IN FEBRUARY 2021
* MGC PHARMA WILL BE ONE OF FIRST CANNABIS-SECTOR COMPANIES TO IPO ON MAIN MARKET OF LSE IN UK
* MGC PHARMA WILL RETAIN ITS PRIMARY LISTING ON AUSTRALIAN STOCK EXCHANGE